Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Is pharma providing relevant social media web content?

Richard Meyer
Social media
September 14, 2010
Share
Tweet
Share

Some people are disappointed at the latest FDA notice to Novartis over a Facebook button on one of their website pages.

The key question that a lot of people fail to ask is “do patients want to have a conversation with a drug company?”  From almost one year of qualitative and quantitative research plus other 3rd party research (i.e. Rodale DTC Study) the answer to that is “no.”

Now before you get your bowels in an uproar here are some things to think about:

1. What would the conversation be about? Pharma obviously could not talk to patients about symptoms, or how to take their medications.  This would not only open the flood gates for lawyers it might get physicians upset as they might feel a drug company is coming between the physician-patient relationship.

2. Who would they talk to? Marketers?  Medical people?  In case you hadn’t noticed, pharma is laying off people left and right and legal/regulatory people would have a stroke if someone talked to patients without screening the conversation.

3. What is the value to the patient? Patients can get a lot more information at other sites including a wealth of social media health sites.  Since the trust in pharma and the FDA is at an all time low what makes anyone think that there could be a conversation based on trust.

Now does this apply to 100% of the industry ?  No, maybe a company like Dendreon could advise patients via social media where they are in providing cancer patients with their new Provenge. However the conversation could quickly turn ugly as patients awaiting treatment try to get to the head of the line and question the cost.

The value in social media for pharma is to bring people together to share insights into treatment options and health issues.  They can help get good credible information to patients and by providing deep links and thus reducing the amount of time consumers need to get the key information they need to make informed decisions.

There is no way that the conservative FDA is going to allow patients to confer with pharma unless it’s to report an adverse event if they won’t even allow a Facebook button on a product website.   More and more the FDA is handcuffing pharma in social media but pharma is also not doing enough when it comes to serving up personally relevant web content.

It has been my experience that scientists and medical people have a hard time understanding marketing because marketing is not based on science, consumers do not act rational on or offline.   As for a conversation with pharma?  It ain’t happening, so better start thinking outside the box and within FDA guidelines or else the marketing of prescription drugs to consumers will become a secondary source of information that will be ignored by patients.

Richard Meyer is Executive Director/Principal at Online Strategic Solutions and blogs at World of DTC Marketing.com.

Submit a guest post and be heard.

Prev

iPhone App Store medical section and real medical apps

September 14, 2010 Kevin 0
…
Next

Emergency department utilization and its impact on health care reform

September 15, 2010 Kevin 4
…

ADVERTISEMENT

Tagged as: Facebook, Medications, Twitter

Post navigation

< Previous Post
iPhone App Store medical section and real medical apps
Next Post >
Emergency department utilization and its impact on health care reform

ADVERTISEMENT

More by Richard Meyer

  • 7 reasons why DTC drug marketing will decline in 2013

    Richard Meyer
  • a desk with keyboard and ipad with the kevinmd logo

    Mobile health apps don’t always follow conventional wisdom

    Richard Meyer
  • a desk with keyboard and ipad with the kevinmd logo

    How can pharma earn the trust of patients?

    Richard Meyer

More in Social media

  • First impressions happen online—not in your exam room

    Sara Meyer
  • What teenagers on TikTok are saying about skin care—and why that’s a problem

    Khushali Jhaveri, MD
  • How social media and telemedicine are transforming patient care

    Jalene Jacob, MD, MBA
  • How DrKoop.com rose and fell: the untold story behind the Surgeon General’s startup

    Nigel Cameron, PhD
  • How I escaped the toxic grip of social media

    Dr. Damane Zehra
  • Why doctors must fight health misinformation on social media

    Olapeju Simoyan, MD
  • Most Popular

  • Past Week

    • Why your clinic waiting room may affect patient outcomes

      Ziya Altug, PT, DPT and Shirish Sachdeva, PT, DPT | Conditions
    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • The ethical crossroads of medicine and legislation

      M. Bennet Broner, PhD | Conditions
    • How community and buses saved my retirement

      Raymond Abbott | Conditions
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
  • Recent Posts

    • How policy and stigma block addiction treatment

      Mariana Ndrio, MD | Physician
    • Unused IV catheters cost U.S. hospitals billions

      Piyush Pillarisetti | Policy
    • Why U.S. universities should adopt a standard pre-med major [PODCAST]

      The Podcast by KevinMD | Podcast
    • Ancient health secrets for modern life

      Larry Kaskel, MD | Conditions
    • How the internet broke the doctor-parent trust

      Wendy L. Hunter, MD | Conditions
    • Why don’t women in medicine support each other?

      Jessie Mahoney, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why your clinic waiting room may affect patient outcomes

      Ziya Altug, PT, DPT and Shirish Sachdeva, PT, DPT | Conditions
    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • The ethical crossroads of medicine and legislation

      M. Bennet Broner, PhD | Conditions
    • How community and buses saved my retirement

      Raymond Abbott | Conditions
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
  • Recent Posts

    • How policy and stigma block addiction treatment

      Mariana Ndrio, MD | Physician
    • Unused IV catheters cost U.S. hospitals billions

      Piyush Pillarisetti | Policy
    • Why U.S. universities should adopt a standard pre-med major [PODCAST]

      The Podcast by KevinMD | Podcast
    • Ancient health secrets for modern life

      Larry Kaskel, MD | Conditions
    • How the internet broke the doctor-parent trust

      Wendy L. Hunter, MD | Conditions
    • Why don’t women in medicine support each other?

      Jessie Mahoney, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Is pharma providing relevant social media web content?
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...